Comorbid ADHD/Depression Treated with Bupropion SR
A trial of bupropion sustained release (SR) was conducted in 24 adolescents (ages 11-16 years) with ADHD and either major depressive disorder or dysthymic disorder at the Department of Psychiatry, Dartmouth Medical School, Hanover, NH.
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2001-03-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/1810 |
Similar Items
-
Bupropion v. Methylphenidate in ADHD
by: J Gordon Millichap
Published: (1995-06-01) -
Dysthymia and Major Depressive Disorders Compared
by: J Gordon Millichap
Published: (1994-06-01) -
THE EFFECTIVENESS OF BUPROPION SR ON DEPRESSIVE SYMPTOMS IN SMOKERS: SELF-REPORTS, EEG, AND INDIVIDUAL DIFFERENCES
by: Zhu, Jian
Published: (2015) -
Seizures After Overdoses of Bupropion Intake
by: Hasan Kara, et al.
Published: (2013-06-01) -
Study on psychiatric morbidities in patients with newly (recently) detected type 2 diabetes mellitus
by: Adya Shanker Srivastava, et al.
Published: (2016-07-01)